Cardiovascular Research

Interactions between coronary occlusion and the renin-angiotensin system in the dog.

Authors: G Ertl|||R W Alexander|||R A Kloner

Affiliations: + Expand

Abstract

Studies were carried out in 39 barbiturate-anesthetized dogs to determine whether the renin-angiotensin system is important in control of hemodynamics and coronary flow during myocardial ischemia. Plasma renin activity (PRA) was 2.2 +/- 0.4 ng x ml-l x hr-1 immediately before coronary artery occlusion (CAO) and increased to 3.8 +/- 0.5 (p less than .005) 15 minutes after CAO. In nephrectomized dogs, PRA was 0.76 +/- 0.14 ng x ml-l x hr-1 two hours after nephrectomy and remained unchanged after CAO. In contrast, hemodynamic changes following CAO were similar between nephrectomized and intact dogs: mean arterial pressure fell from 126 +/- 4 pre CAO to 116 +/- 4 mm Hg post CAO (p less than 0.005) in nephrectomized dogs and from 130 +/- 11 to 120 +/- 11 mm Hg (p less than 0.005) in intact dogs. Left atrial pressure rose from 5.4 +/- 0.9 pre CAO to 7.7 +/- 0.9 mm Hg (p less than 0.005) post CAO in nephrectomized from 5.4 +/- 0.9 pre CAO to 7.7 +/- 0.9 mm Hg (p less than 0.005) post CAO in nephrectomized dogs and 6.3 +/- 1.3 to 9.0 +/- 1.8 mm Hg (p less than 0.005) in intact dogs. Heart rate remained unchanged in both groups. In sham-operated dogs without CAO, neither the angiotensin II blocker Saralasin nor the converting enzyme inhibitor Captopril had significant effects on systemic (SVR) and coronary (CVR) vascular resistances. In contrast, in dogs with CAO, these drugs reduced CVR from 1.28 +/- 0.13 mm Hg x ml-1 x min x 100 g heart weight (resistance units = RU) to 0.85 +/- 0.08 RU (p less than 0.05) (Saralasin) 15 minutes after treatment and from 1.17 +/- 0.09 to 0.88 +/- 0.08 RU (p less than 0.025), (Captopril) respectively. However, only Captopril reduced SVR, from 10.7 +/- 1.13 to 8.2 +/- 0.8 RU (p less than 0.025). Both Captopril and Saralasin induced a significant increase in collateral blood flow. Nephrectomy, two hours prior to CAO, significant increase in collateral blood flow. Nephrectomy, two hours prior to CAO, significantly reduced the effect of Captopril on CVR and collateral blood flow while the effect on SVR persisted. Thus the reduction in CVR appears to be an effect of inhibition of the renin-angiotensin system; this system participates in control of CVR during CAO and may limit coronary collateral blood flow.

---

Chemical List

Captopril|||Saralasin

---

Reference List

Circ Res. 1979 Jun;44(6):796-9|||J Clin Invest. 1975 Jun;55(6):1174-81|||Kidney Int Suppl. 1979 Mar;(9):S20-8|||Circulation. 1982 Jan;65(1):40-8|||Circ Res. 1978 Feb;42(2):237-45|||Am J Physiol. 1961 May;200:995-8|||Am J Physiol. 1982 Jan;242(1):H107-12|||Proc Soc Exp Biol Med. 1974 Nov;147(2):387-91|||Circ Res. 1980 Jul;47(1):108-16|||Circ Res. 1979 Jul;45(1):13-25|||Hypertension. 1980 Mar-Apr;2(2):119-24|||J Lab Clin Med. 1973 Apr;81(4):632-40|||Life Sci. 1979 Feb 5;24(6):503-12|||Cardiovasc Res. 1976 Jan;10(1):81-90|||Lab Invest. 1979 Jun;40(6):633-44|||Clin Sci Mol Med Suppl. 1975 Jun;2:3s-14s|||Science. 1972 Sep 22;177(4054):1108-9|||Circ Res. 1973 May 5;32:Suppl 1:159-68|||Am J Physiol. 1980 Sep;239(3):H342-8|||Res Commun Chem Pathol Pharmacol. 1978 May;20(2):289-302|||J Clin Invest. 1978 Apr;61(4):874-83|||Am Heart J. 1973 May;85(5):635-47|||Prog Cardiovasc Dis. 1977 Jul-Aug;20(1):55-79|||Kidney Int Suppl. 1979 Mar;(9):S11-9|||Circ Res. 1979 Dec;45(6):728-36|||Circ Res. 1978 Oct;43(4):512-9|||Am J Cardiol. 1974 Jan;33(1):60-8|||Eur J Clin Invest. 1979 Dec;9(6):447-9|||Clin Sci Mol Med. 1977 Mar;52(3):299-304|||Arch Int Pharmacodyn Ther. 1966 Sep;163(1):219-26|||Physiol Rev. 1976 Jan;56(1):1-56